The addition of lenalidomide shows no clear benefit for older patients with acute myeloid leukaemia receiving treatment with standard remission induction chemotherapy, according to data from a phase II trial.
Routinely used for treating cardiovascular diseases, statins have been shown to benefit other conditions, and new evidence suggests that using the drug at high intensity reduces the risk of hip or knee replacement, an effect that may be specific to rheumatoid arthritis.
Use of biologic medications to treat erythrodermic psoriasis (EP) is well-tolerated by and induces positive responses in patients, with a weak recommendation and limited quality of evidence in favour of infliximab, ustekinumab, ixekizumab, and guselkumab, a recent study has shown.
Use of 5% Pueraria mirifica vaginal gel in women with genitourinary syndrome of menopause effectively reduces indicators of bacterial vaginosis but does little to alleviate genitourinary symptoms, according to the results of a trial.
Treatment with the combination of sorafenib plus hepatic arterial infusion chemotherapy appears to be effective and well tolerated in patients with advanced hepatocellular carcinoma, according to the results of a meta-analysis.
In Japanese patients with type 2 diabetes (T2D), sodium-glucose cotransporter 2 inhibitors pose less of a cardiovascular risk than other glucose-lowering drugs and dipeptidyl peptidase-4 inhibitors, a new study has shown.
In morbidly obese hospitalized patients, high-fixed dose unfractionated heparin for the prevention of venous thromboembolism is associated with a higher risk of major bleeding events compared with high-fixed dose enoxaparin, a recent study has shown.
Treatment with Lactobacillus crispatus CTV-05 (Lactin-V) significantly reduces the incidence of bacterial vaginosis recurrence in women who were previously treated with vaginal metronidazole, according to a recent study.
Concomitant use of fimasartan and rosuvastatin in patients with hypertension and dyslipidaemia does not appear to be synergistic in increasing concurrent control rate of the diseases, although either drug is effective against the target disease, according to a study.
The prescription omega-3 fatty acid icosapent ethyl significantly reduces the need for revascularization in patients with elevated triglycerides who were already on statins and were at increased cardiovascular (CV) risk, reveals the latest data from the REDUCE-IT REVASC analysis presented during the SCAI* 2020 Meeting.